title: Low ABCB1 gene expression is an early event in colorectal carcinogenesis.
abstract: The ABCB1/MDR1 gene product ABCB1/P-glycoprotein is implicated in the development of colorectal cancer (CRC). NFKB1 encodes transcription factors regulating expression of a number of genes including ABCB1. We have previously found association between the ABCB1 C-rs3789243-T polymorphism and CRC risk and interactions between the ABCB1 C-rs3789243-T and C3435T polymorphisms and meat intake in relation to CRC risk (Andersen, BMC Cancer, 2009, 9, 407). ABCB1 and NFKB1 mRNA levels were assessed in intestinal tissue from 122 CRC cases, 101 adenoma cases (12 with severe dysplasia, 89 with mild-moderate dysplasia) and from 18 healthy individuals, together with gene polymorphisms in ABCB1 and NFKB1. ABCB1 mRNA levels were highest in the healthy individuals and significantly lower in mild/moderate and severe dysplasia tissue (P<0.05 for both), morphologically normal tissues close to the tumour (P<0.05), morphologically normal tissue at a distance from the tumour (P<0.05) and CRC tissue (P<0.001). Furthermore, ABCB1 mRNA levels were lower in adenomas and carcinomas compared to morphologically normal tissue from the same individuals (P<0.01). The ABCB1 C-rs3789243-T and NFKB1 -94ins/del homozygous variant genotypes were associated with low ABCB1 mRNA levels in morphologically normal sigmoid tissue from adenoma cases (P<0.05 for both). NFKB1 mRNA levels were lower in both tumour and normal tissue from cancer patients (P<0.001) as compared to healthy individuals but we were unable to show association between NFKB1 -94ins/del genotype and NFKB1 mRNA levels. This study suggests that low ABCB1 mRNA levels are an early event in CRC development and that the two polymorphisms affect ABCB1 mRNA levels whereas low NFKB1 mRNA levels occur later in carcinogenesis. Low ABCB1 protein levels may promote colorectal carcinogenesis through increasing intracellular exposure to carcinogenic ABCB1 substrates.
authors: Medical Department, Hospital of Southern Jutland, Aabenraa, Denmark ; Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark ; Medical Department, Regional Hospital Viborg, Viborg, Denmark.
authors: Vibeke
authors: V
authors: Andersen
authors: Ulla
authors: U
authors: Vogel
authors: Sine
authors: S
authors: Godiksen
authors: Franz B
authors: FB
authors: Frenzel
authors: Mona
authors: M
authors: Sæbø
authors: Julian
authors: J
authors: Hamfjord
authors: Elin
authors: E
authors: Kure
authors: Lotte K
authors: LK
authors: Vogel
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics / Q000378:metabolism*; D000236:Adenoma / Q000378:metabolism* / Q000473:pathology; D063646:Carcinogenesis / Q000378:metabolism*; D002277:Carcinoma / Q000378:metabolism* / Q000473:pathology; D016022:Case-Control Studies; D003106:Colon / Q000378:metabolism; D015179:Colorectal Neoplasms / Q000378:metabolism* / Q000473:pathology; D005260:Female; D015870:Gene Expression; D006801:Humans; D054643:INDEL Mutation; D008297:Male; D008875:Middle Aged; D052002:NF-kappa B p50 Subunit / Q000235:genetics / Q000378:metabolism; D020641:Polymorphism, Single Nucleotide; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism
chemical_list: C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D052002:NF-kappa B p50 Subunit; C489548:NFKB1 protein, human; D012333:RNA, Messenger
references: PLoS One. 2012;7(9):e46295
references: 23050008
references: Cancer Metastasis Rev. 2013 Jun;32(1-2):39-61
references: 23076650
references: Pharmacogenomics J. 2007 Feb;7(1):56-65
references: 16788565
references: Eur J Cancer. 1995 Jul-Aug;31A(7-8):1291-4
references: 7577038
references: Colorectal Dis. 2013 Jan;15(1):12-8
references: 23279665
references: Aliment Pharmacol Ther. 2013 Feb;37(4):383-91
references: 23216531
references: Anticancer Res. 2008 Nov-Dec;28(6B):3921-8
references: 19192650
references: Curr Drug Metab. 2008 Feb;9(2):167-74
references: 18288958
references: Eur J Cancer Prev. 2005 Aug;14(4):373-9
references: 16030428
references: Pharmacogenetics. 2003 Aug;13(8):481-94
references: 12893986
references: Scand J Clin Lab Invest. 2007;67(2):123-34
references: 17365992
references: Hum Mol Genet. 2004 Jan 1;13(1):35-45
references: 14613970
references: Atherosclerosis. 2011 Nov;219(1):200-4
references: 21726863
references: BMC Cancer. 2010 Sep 13;10:484
references: 20836841
references: Nucleic Acids Res. 1988 Feb 11;16(3):1215
references: 3344216
references: Scand J Gastroenterol. 2009;44(1):65-73
references: 18819034
references: BMC Med Genet. 2009 Feb 27;10:18
references: 19250544
references: BMC Cancer. 2009 Nov 21;9:407
references: 19930591
references: BMJ. 1998 Apr 18;316(7139):1236-8
references: 9553006
references: BMC Cancer. 2007 Dec 19;7:228
references: 18093316
references: PLoS One. 2012;7(3):e32784
references: 22396794